Infimab 100 mg is a biologic medicine containing infliximab, designed to reduce excessive inflammation by targeting TNF-α, a protein that plays an important role in inflammatory immune responses. By lowering the activity of this inflammatory pathway, it helps control the symptoms and progression of certain chronic inflammatory and autoimmune conditions. Infimab is administered by intravenous infusion under medical supervision.